Reversal of ABCB1- and ABCG2-mediated MDR by erlotinib (tarceva, OSI-774) Proceedings (Faculty180)

cited authors

  • Shi, Z; Peng, X x; Kim, I W; Shukla, S; Tiwari, Amit K; Si, Q S; Robey, R W; Bates, S E; Wang, S; Chi,, C; Shen, T; Ashby, Charles; Fu, L W; Ambudkar, S V; Chen, Z S

publication date

  • 2008

presented at event